Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Eric Roselli, MD

216.444.0995

Eric Roselli, MD
Department: Thoracic and Cardiovascular Surgery
Location: Cleveland Clinic Main Campus
Mail Code J4-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.0995
DeskDesk:216.444.2480
WorkFax:216.636.1393
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Eric Roselli, MD, is a Staff Surgeon in the Cleveland Clinic Department of Thoracic and Cardiovascular Surgery and on the teaching faculty at the Cleveland Clinic Lerner College of Medicine. He is certified by the American Board of Surgery and the American Board of Thoracic Surgery. Dr. Roselli's specialty interests include adult cardiac surgery, thoracic aortic surgery, endovascular stent graft therapy, minimally invasive valve repair and replacement, high-risk valve surgery, endovascular stent and prosthetic valve research, and surgical education.

Dr. Roselli did his undergraduate work at the University of Michigan where he received the David J. Hallisey Memorial Academic Scholarship. He received his medical degree from Loyola University Chicago Stritch School of Medicine, graduating in 1997 "with distinction." He completed residencies in both surgery, and thoracic and cardiovascular surgery at Cleveland Clinic followed by additional training in catheter-based interventions and endovascular surgery. He was appointed to Cleveland Clinic in 2005 in the Department of Thoracic and Cardiovascular Surgery.

He has authored or co-authored several book chapters and articles in peer-reviewed journals on root, arch, and thoracoabdominal aortic aneurysms, endovascular aortic surgery, reoperative cardiac surgery, aortic valve disease, cardiac tumors, cardiac CT, atrial fibrillation, and transcatheter aortic valve development. Dr Roselli participates in the peer review process as a reviewer for prestigious medical journals.

Dr Roselli's research is focused on thoracic aortic dissection and aneurysms, and aortic valve and multi-valve disease. Specifically, his projects are directed at improving and developing safer and less invasive approaches to treat these problems. He is regularly invited to present his research at medical and surgical conferences worldwide.

Dr. Roselli is a Fellow of the American College of Surgeons and a member of the American College of Cardiology.  He has served as a chairman and member of the program committee for multiple national meetings, co-authored practice guidelines for the treatment of cardiovascular diseases, and is an active member of the Society of Thoracic Surgeons.  He is also a member of the International Society of Minimally Invasive Cardiac Surgery and is Chair of the Committee on Post-graduate Education for the Joint Council on Thoracic Surgical Education.

Education & Fellowships

Residency - Cleveland Clinic
Thoracic Surgery
Cleveland, OH USA
2005
Residency - Cleveland Clinic
General Surgery
Cleveland, OH USA
2002
Internship - Cleveland Clinic
General Surgery
Cleveland, OH USA
1998
Medical School - Loyola University Stritch School of Medicine
Chicago, IL USA
1997
Undergraduate - University of Michigan
Science/Philosophy
Ann Arbor, MI USA
1993

Certifications

  • Surgery
  • Thoracic & Cardiac Surgery

Specialty Interests

Cardiac surgery, surgery for thoracic aortic aneurysm, endovascular aorta treatment - thoracic, surgery reoperation, heart valve surgery, high risk reoperation surgery, minimally invasive cardiac surgery, percutaneous valve treatment

Awards & Honors

  • Dr. Charles H. Bryan Annual Award for Clinical Excellence in Thoracic and Cardiovascular Surgery, Cleveland Clinic, 2005
  • Bruce W. Lytle Master Clinical Instructor Award (Teacher of the Year), 2008

Additional Training

Endovascular Surgery Fellowship, Cleveland Clinic

Innovations & Patents

Dr. Roselli is one of only a few "hybrid" specialists trained in both open surgical and interventional techniques for the treatment of complex structural heart (aortic and mitral valve) and thoracic aortic disease (aneurysms and dissection).   He has been instrumental in the development of several new less invasive approaches used to treat complex cardiovascular disease.

Memberships

  • Society of Thoracic Surgery, Workforce on Adult Cardiac Surgery
  • International Society of Minimally Invasive Cardiac Surgery, Program Committee
  • American College of Surgeons
  • American College of Cardiology

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/5/2014, Dr. Roselli has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Roselli receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Cook Medical
  • Direct Flow Medical, Inc.
  • Edwards Lifesciences LLC
  • Medtronic, Inc.
  • Vascutek Ltd.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English